Fundz

On Kure Therapeutics reported raising $65 Million in an initial SEC Form D filing, from an offering of $65 Million

PRIVATEOct 21, 2024

Amount Raised

$65 Million

$65 Million sold, per SEC Form D (first sale Oct 4, 2024)

Round Type

Venture

BoulderBiotechnologyHealthcareTherapeuticsPharmaceuticalBiopharma

Who to call at OnKure Therapeutics, and when

A new round usually means OnKure Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OnKure Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OnKure Therapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OnKure Therapeutics

Location

6707 WINCHESTER CIRCLE

Boulder, Colorado, United States

About

OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines that target biologically significant and well-validated pharmacological pathways, with a focus on oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OnKure Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts47 people are listed at OnKure Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for OnKure Therapeutics's next move

See what Strategic adds

OnKure Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.